Figure 1
Figure 1. Flow cytometry–based immunologic profiling: representative flow plots and gating strategy. (A) Gating strategy by flow cytometry for the detection of CD4+ and CD8+ T cells (singlet [forward scatter A{FSC-A} × FSC-H diagonal] live [Aqua] CD3+ lymphocytes) extracted from rectosigmoid biopsy tissue (RB, top panels) and from peripheral blood (PB, bottom panels). (B) Detection of CD38 and Ki67 expression in CD8+ T cells (left) as well as FoxP3 and Ki67 in CD8+ and CD4+ T cells from rectosigmoid biopsy tissue (top) and from peripheral blood (bottom). (C-D) Antigen-specific CD8+ (top) CD4+ (bottom) T-cell responses in peripheral blood after stimulation with PBS (mock), CMV, HIV, Candida albicans (C alb), or SEB antigens, as measured by CFSElow proliferative responses (C) or IFNγ intracellular cytokine detection (D). (E) Detection of intracellular cytokines (IFNγ, IL-2, IL-17, or TNFα) in CD4+ T cells from rectosigmoid biopsy tissue (top) and from peripheral blood (bottom), after PMA/ionomycin stimulation in vitro. All of these analyses were carried out using cells from a representative noncontroller (1256).

Flow cytometry–based immunologic profiling: representative flow plots and gating strategy. (A) Gating strategy by flow cytometry for the detection of CD4+ and CD8+ T cells (singlet [forward scatter A{FSC-A} × FSC-H diagonal] live [Aqua] CD3+ lymphocytes) extracted from rectosigmoid biopsy tissue (RB, top panels) and from peripheral blood (PB, bottom panels). (B) Detection of CD38 and Ki67 expression in CD8+ T cells (left) as well as FoxP3 and Ki67 in CD8+ and CD4+ T cells from rectosigmoid biopsy tissue (top) and from peripheral blood (bottom). (C-D) Antigen-specific CD8+ (top) CD4+ (bottom) T-cell responses in peripheral blood after stimulation with PBS (mock), CMV, HIV, Candida albicans (C alb), or SEB antigens, as measured by CFSElow proliferative responses (C) or IFNγ intracellular cytokine detection (D). (E) Detection of intracellular cytokines (IFNγ, IL-2, IL-17, or TNFα) in CD4+ T cells from rectosigmoid biopsy tissue (top) and from peripheral blood (bottom), after PMA/ionomycin stimulation in vitro. All of these analyses were carried out using cells from a representative noncontroller (1256).

Close Modal

or Create an Account

Close Modal
Close Modal